The global market for Therapeutic Protein was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Protein.

The Therapeutic Protein market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Therapeutic Protein Market Report

Report Metric	Details
Report Name	Therapeutic Protein Market
CAGR	5%
Segment by Type	Monoclonal Antibodies Erythropoietin Insulin Interferon Human Growth Hormone Follicle Stimulating Hormone Blood Clotting Factors
Segment by Application	Pharmaceutical Companies Healthcare Service Providers Research Organizations Academic Research Institutes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amgen, Abbott Laboratories, AstraZeneca, Baxter International, Boehringer Ingelheim, Chugai Pharmaceutical, Diasome Pharmaceuticals, Eli Lilly, GeneScience Pharmaceuticals, Generex Biotechnology, Genentech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Therapeutic Protein Market report?

Ans: The main players in the Therapeutic Protein Market are Amgen, Abbott Laboratories, AstraZeneca, Baxter International, Boehringer Ingelheim, Chugai Pharmaceutical, Diasome Pharmaceuticals, Eli Lilly, GeneScience Pharmaceuticals, Generex Biotechnology, Genentech

What are the Application segmentation covered in the Therapeutic Protein Market report?

Ans: The Applications covered in the Therapeutic Protein Market report are Pharmaceutical Companies, Healthcare Service Providers, Research Organizations, Academic Research Institutes

What are the Type segmentation covered in the Therapeutic Protein Market report?

Ans: The Types covered in the Therapeutic Protein Market report are Monoclonal Antibodies, Erythropoietin, Insulin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone, Blood Clotting Factors

1 Therapeutic Protein Market Overview

1.1 Product Definition

1.2 Therapeutic Protein by Type

1.2.1 Global Therapeutic Protein Market Value Comparison by Type (2024 VS 2031)

1.2.2 Monoclonal Antibodies

1.2.3 Erythropoietin

1.2.4 Insulin

1.2.5 Interferon

1.2.6 Human Growth Hormone

1.2.7 Follicle Stimulating Hormone

1.2.8 Blood Clotting Factors

1.3 Therapeutic Protein by Application

1.3.1 Global Therapeutic Protein Market Value by Application (2024 VS 2031)

1.3.2 Pharmaceutical Companies

1.3.3 Healthcare Service Providers

1.3.4 Research Organizations

1.3.5 Academic Research Institutes

1.4 Global Therapeutic Protein Market Size Estimates and Forecasts

1.4.1 Global Therapeutic Protein Revenue 2020-2031

1.4.2 Global Therapeutic Protein Sales 2020-2031

1.4.3 Global Therapeutic Protein Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Therapeutic Protein Market Competition by Manufacturers

2.1 Global Therapeutic Protein Sales Market Share by Manufacturers (2020-2025)

2.2 Global Therapeutic Protein Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Therapeutic Protein Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Therapeutic Protein, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Therapeutic Protein, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Therapeutic Protein, Product Type & Application

2.7 Global Key Manufacturers of Therapeutic Protein, Date of Enter into This Industry

2.8 Global Therapeutic Protein Market Competitive Situation and Trends

2.8.1 Global Therapeutic Protein Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Therapeutic Protein Players Market Share by Revenue

2.8.3 Global Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Therapeutic Protein Market Scenario by Region

3.1 Global Therapeutic Protein Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Therapeutic Protein Sales by Region: 2020-2031

3.2.1 Global Therapeutic Protein Sales by Region: 2020-2025

3.2.2 Global Therapeutic Protein Sales by Region: 2026-2031

3.3 Global Therapeutic Protein Revenue by Region: 2020-2031

3.3.1 Global Therapeutic Protein Revenue by Region: 2020-2025

3.3.2 Global Therapeutic Protein Revenue by Region: 2026-2031

3.4 North America Therapeutic Protein Market Facts & Figures by Country

3.4.1 North America Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Therapeutic Protein Sales by Country (2020-2031)

3.4.3 North America Therapeutic Protein Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Therapeutic Protein Market Facts & Figures by Country

3.5.1 Europe Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Therapeutic Protein Sales by Country (2020-2031)

3.5.3 Europe Therapeutic Protein Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Therapeutic Protein Market Facts & Figures by Region

3.6.1 Asia Pacific Therapeutic Protein Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Therapeutic Protein Sales by Region (2020-2031)

3.6.3 Asia Pacific Therapeutic Protein Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Therapeutic Protein Market Facts & Figures by Country

3.7.1 Latin America Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Therapeutic Protein Sales by Country (2020-2031)

3.7.3 Latin America Therapeutic Protein Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Therapeutic Protein Market Facts & Figures by Country

3.8.1 Middle East and Africa Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Therapeutic Protein Sales by Country (2020-2031)

3.8.3 Middle East and Africa Therapeutic Protein Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Therapeutic Protein Sales by Type (2020-2031)

4.1.1 Global Therapeutic Protein Sales by Type (2020-2025)

4.1.2 Global Therapeutic Protein Sales by Type (2026-2031)

4.1.3 Global Therapeutic Protein Sales Market Share by Type (2020-2031)

4.2 Global Therapeutic Protein Revenue by Type (2020-2031)

4.2.1 Global Therapeutic Protein Revenue by Type (2020-2025)

4.2.2 Global Therapeutic Protein Revenue by Type (2026-2031)

4.2.3 Global Therapeutic Protein Revenue Market Share by Type (2020-2031)

4.3 Global Therapeutic Protein Price by Type (2020-2031)

5 Segment by Application

5.1 Global Therapeutic Protein Sales by Application (2020-2031)

5.1.1 Global Therapeutic Protein Sales by Application (2020-2025)

5.1.2 Global Therapeutic Protein Sales by Application (2026-2031)

5.1.3 Global Therapeutic Protein Sales Market Share by Application (2020-2031)

5.2 Global Therapeutic Protein Revenue by Application (2020-2031)

5.2.1 Global Therapeutic Protein Revenue by Application (2020-2025)

5.2.2 Global Therapeutic Protein Revenue by Application (2026-2031)

5.2.3 Global Therapeutic Protein Revenue Market Share by Application (2020-2031)

5.3 Global Therapeutic Protein Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Amgen

6.1.1 Amgen Company Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Amgen Therapeutic Protein Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Abbott Laboratories

6.2.1 Abbott Laboratories Company Information

6.2.2 Abbott Laboratories Description and Business Overview

6.2.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Abbott Laboratories Therapeutic Protein Product Portfolio

6.2.5 Abbott Laboratories Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AstraZeneca Therapeutic Protein Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Baxter International

6.4.1 Baxter International Company Information

6.4.2 Baxter International Description and Business Overview

6.4.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Baxter International Therapeutic Protein Product Portfolio

6.4.5 Baxter International Recent Developments/Updates

6.5 Boehringer Ingelheim

6.5.1 Boehringer Ingelheim Company Information

6.5.2 Boehringer Ingelheim Description and Business Overview

6.5.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Boehringer Ingelheim Therapeutic Protein Product Portfolio

6.5.5 Boehringer Ingelheim Recent Developments/Updates

6.6 Chugai Pharmaceutical

6.6.1 Chugai Pharmaceutical Company Information

6.6.2 Chugai Pharmaceutical Description and Business Overview

6.6.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Chugai Pharmaceutical Therapeutic Protein Product Portfolio

6.6.5 Chugai Pharmaceutical Recent Developments/Updates

6.7 Diasome Pharmaceuticals

6.7.1 Diasome Pharmaceuticals Company Information

6.7.2 Diasome Pharmaceuticals Description and Business Overview

6.7.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Diasome Pharmaceuticals Therapeutic Protein Product Portfolio

6.7.5 Diasome Pharmaceuticals Recent Developments/Updates

6.8 Eli Lilly

6.8.1 Eli Lilly Company Information

6.8.2 Eli Lilly Description and Business Overview

6.8.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Eli Lilly Therapeutic Protein Product Portfolio

6.8.5 Eli Lilly Recent Developments/Updates

6.9 GeneScience Pharmaceuticals

6.9.1 GeneScience Pharmaceuticals Company Information

6.9.2 GeneScience Pharmaceuticals Description and Business Overview

6.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.9.4 GeneScience Pharmaceuticals Therapeutic Protein Product Portfolio

6.9.5 GeneScience Pharmaceuticals Recent Developments/Updates

6.10 Generex Biotechnology

6.10.1 Generex Biotechnology Company Information

6.10.2 Generex Biotechnology Description and Business Overview

6.10.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Generex Biotechnology Therapeutic Protein Product Portfolio

6.10.5 Generex Biotechnology Recent Developments/Updates

6.11 Genentech

6.11.1 Genentech Company Information

6.11.2 Genentech Description and Business Overview

6.11.3 Genentech Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Genentech Therapeutic Protein Product Portfolio

6.11.5 Genentech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Therapeutic Protein Industry Chain Analysis

7.2 Therapeutic Protein Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Therapeutic Protein Production Mode & Process Analysis

7.4 Therapeutic Protein Sales and Marketing

7.4.1 Therapeutic Protein Sales Channels

7.4.2 Therapeutic Protein Distributors

7.5 Therapeutic Protein Customer Analysis

8 Therapeutic Protein Market Dynamics

8.1 Therapeutic Protein Industry Trends

8.2 Therapeutic Protein Market Drivers

8.3 Therapeutic Protein Market Challenges

8.4 Therapeutic Protein Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Chugai Pharmaceutical

Diasome Pharmaceuticals

Eli Lilly

GeneScience Pharmaceuticals

Generex Biotechnology

Genentech Inc

List of Tables

Table 1. Global Therapeutic Protein Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Therapeutic Protein Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Therapeutic Protein Market Competitive Situation by Manufacturers in 2024

Table 4. Global Therapeutic Protein Sales (K MT) of Key Manufacturers (2020-2025)

Table 5. Global Therapeutic Protein Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Therapeutic Protein Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Therapeutic Protein Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Therapeutic Protein Average Price (USD/MT) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Therapeutic Protein, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Therapeutic Protein, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Therapeutic Protein, Product Type & Application

Table 12. Global Key Manufacturers of Therapeutic Protein, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Protein as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Therapeutic Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Therapeutic Protein Sales by Region (2020-2025) & (K MT)

Table 18. Global Therapeutic Protein Sales Market Share by Region (2020-2025)

Table 19. Global Therapeutic Protein Sales by Region (2026-2031) & (K MT)

Table 20. Global Therapeutic Protein Sales Market Share by Region (2026-2031)

Table 21. Global Therapeutic Protein Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Therapeutic Protein Revenue Market Share by Region (2020-2025)

Table 23. Global Therapeutic Protein Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Therapeutic Protein Revenue Market Share by Region (2026-2031)

Table 25. North America Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Therapeutic Protein Sales by Country (2020-2025) & (K MT)

Table 27. North America Therapeutic Protein Sales by Country (2026-2031) & (K MT)

Table 28. North America Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Therapeutic Protein Sales by Country (2020-2025) & (K MT)

Table 32. Europe Therapeutic Protein Sales by Country (2026-2031) & (K MT)

Table 33. Europe Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Therapeutic Protein Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Therapeutic Protein Sales by Region (2020-2025) & (K MT)

Table 37. Asia Pacific Therapeutic Protein Sales by Region (2026-2031) & (K MT)

Table 38. Asia Pacific Therapeutic Protein Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Therapeutic Protein Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Therapeutic Protein Sales by Country (2020-2025) & (K MT)

Table 42. Latin America Therapeutic Protein Sales by Country (2026-2031) & (K MT)

Table 43. Latin America Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Therapeutic Protein Sales by Country (2020-2025) & (K MT)

Table 47. Middle East and Africa Therapeutic Protein Sales by Country (2026-2031) & (K MT)

Table 48. Middle East and Africa Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Therapeutic Protein Sales (K MT) by Type (2020-2025)

Table 51. Global Therapeutic Protein Sales (K MT) by Type (2026-2031)

Table 52. Global Therapeutic Protein Sales Market Share by Type (2020-2025)

Table 53. Global Therapeutic Protein Sales Market Share by Type (2026-2031)

Table 54. Global Therapeutic Protein Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Therapeutic Protein Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Therapeutic Protein Revenue Market Share by Type (2020-2025)

Table 57. Global Therapeutic Protein Revenue Market Share by Type (2026-2031)

Table 58. Global Therapeutic Protein Price (USD/MT) by Type (2020-2025)

Table 59. Global Therapeutic Protein Price (USD/MT) by Type (2026-2031)

Table 60. Global Therapeutic Protein Sales (K MT) by Application (2020-2025)

Table 61. Global Therapeutic Protein Sales (K MT) by Application (2026-2031)

Table 62. Global Therapeutic Protein Sales Market Share by Application (2020-2025)

Table 63. Global Therapeutic Protein Sales Market Share by Application (2026-2031)

Table 64. Global Therapeutic Protein Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Therapeutic Protein Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Therapeutic Protein Revenue Market Share by Application (2020-2025)

Table 67. Global Therapeutic Protein Revenue Market Share by Application (2026-2031)

Table 68. Global Therapeutic Protein Price (USD/MT) by Application (2020-2025)

Table 69. Global Therapeutic Protein Price (USD/MT) by Application (2026-2031)

Table 70. Amgen Company Information

Table 71. Amgen Description and Business Overview

Table 72. Amgen Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Amgen Therapeutic Protein Product

Table 74. Amgen Recent Developments/Updates

Table 75. Abbott Laboratories Company Information

Table 76. Abbott Laboratories Description and Business Overview

Table 77. Abbott Laboratories Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Abbott Laboratories Therapeutic Protein Product

Table 79. Abbott Laboratories Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. AstraZeneca Therapeutic Protein Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Baxter International Company Information

Table 86. Baxter International Description and Business Overview

Table 87. Baxter International Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. Baxter International Therapeutic Protein Product

Table 89. Baxter International Recent Developments/Updates

Table 90. Boehringer Ingelheim Company Information

Table 91. Boehringer Ingelheim Description and Business Overview

Table 92. Boehringer Ingelheim Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Boehringer Ingelheim Therapeutic Protein Product

Table 94. Boehringer Ingelheim Recent Developments/Updates

Table 95. Chugai Pharmaceutical Company Information

Table 96. Chugai Pharmaceutical Description and Business Overview

Table 97. Chugai Pharmaceutical Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Chugai Pharmaceutical Therapeutic Protein Product

Table 99. Chugai Pharmaceutical Recent Developments/Updates

Table 100. Diasome Pharmaceuticals Company Information

Table 101. Diasome Pharmaceuticals Description and Business Overview

Table 102. Diasome Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. Diasome Pharmaceuticals Therapeutic Protein Product

Table 104. Diasome Pharmaceuticals Recent Developments/Updates

Table 105. Eli Lilly Company Information

Table 106. Eli Lilly Description and Business Overview

Table 107. Eli Lilly Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. Eli Lilly Therapeutic Protein Product

Table 109. Eli Lilly Recent Developments/Updates

Table 110. GeneScience Pharmaceuticals Company Information

Table 111. GeneScience Pharmaceuticals Description and Business Overview

Table 112. GeneScience Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. GeneScience Pharmaceuticals Therapeutic Protein Product

Table 114. GeneScience Pharmaceuticals Recent Developments/Updates

Table 115. Generex Biotechnology Company Information

Table 116. Generex Biotechnology Description and Business Overview

Table 117. Generex Biotechnology Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. Generex Biotechnology Therapeutic Protein Product

Table 119. Generex Biotechnology Recent Developments/Updates

Table 120. Genentech Company Information

Table 121. Genentech Description and Business Overview

Table 122. Genentech Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 123. Genentech Therapeutic Protein Product

Table 124. Genentech Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Therapeutic Protein Distributors List

Table 128. Therapeutic Protein Customers List

Table 129. Therapeutic Protein Market Trends

Table 130. Therapeutic Protein Market Drivers

Table 131. Therapeutic Protein Market Challenges

Table 132. Therapeutic Protein Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Therapeutic Protein

Figure 2. Global Therapeutic Protein Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Therapeutic Protein Market Share by Type: 2024 & 2031

Figure 4. Monoclonal Antibodies Product Picture

Figure 5. Erythropoietin Product Picture

Figure 6. Insulin Product Picture

Figure 7. Interferon Product Picture

Figure 8. Human Growth Hormone Product Picture

Figure 9. Follicle Stimulating Hormone Product Picture

Figure 10. Blood Clotting Factors Product Picture

Figure 11. Global Therapeutic Protein Market Value by Application (2020-2031) & (US$ Million)

Figure 12. Global Therapeutic Protein Market Share by Application: 2024 & 2031

Figure 13. Pharmaceutical Companies

Figure 14. Healthcare Service Providers

Figure 15. Research Organizations

Figure 16. Academic Research Institutes

Figure 17. Global Therapeutic Protein Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Therapeutic Protein Market Size (2020-2031) & (US$ Million)

Figure 19. Global Therapeutic Protein Sales (2020-2031) & (K MT)

Figure 20. Global Therapeutic Protein Average Price (USD/MT) & (2020-2031)

Figure 21. Therapeutic Protein Report Years Considered

Figure 22. Therapeutic Protein Sales Share by Manufacturers in 2024

Figure 23. Global Therapeutic Protein Revenue Share by Manufacturers in 2024

Figure 24. Global 5 and 10 Largest Therapeutic Protein Players: Market Share by Revenue in Therapeutic Protein in 2024

Figure 25. Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 26. Global Therapeutic Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 27. North America Therapeutic Protein Sales Market Share by Country (2020-2031)

Figure 28. North America Therapeutic Protein Revenue Market Share by Country (2020-2031)

Figure 29. U.S. Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Canada Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Europe Therapeutic Protein Sales Market Share by Country (2020-2031)

Figure 32. Europe Therapeutic Protein Revenue Market Share by Country (2020-2031)

Figure 33. Germany Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. France Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. U.K. Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Italy Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Russia Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Asia Pacific Therapeutic Protein Sales Market Share by Region (2020-2031)

Figure 39. Asia Pacific Therapeutic Protein Revenue Market Share by Region (2020-2031)

Figure 40. China Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Japan Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. South Korea Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. India Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Australia Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Taiwan Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Indonesia Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Thailand Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Malaysia Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Philippines Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Latin America Therapeutic Protein Sales Market Share by Country (2020-2031)

Figure 51. Latin America Therapeutic Protein Revenue Market Share by Country (2020-2031)

Figure 52. Mexico Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Brazil Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Argentina Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Middle East and Africa Therapeutic Protein Sales Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Therapeutic Protein Revenue Market Share by Country (2020-2031)

Figure 57. Turkey Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. UAE Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Global Sales Market Share of Therapeutic Protein by Type (2020-2031)

Figure 61. Global Revenue Market Share of Therapeutic Protein by Type (2020-2031)

Figure 62. Global Therapeutic Protein Price (USD/MT) by Type (2020-2031)

Figure 63. Global Sales Market Share of Therapeutic Protein by Application (2020-2031)

Figure 64. Global Revenue Market Share of Therapeutic Protein by Application (2020-2031)

Figure 65. Global Therapeutic Protein Price (USD/MT) by Application (2020-2031)

Figure 66. Therapeutic Protein Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions